1. A delicate balance: Psychotropic polypharmacy and anti-cholinergic use are correlated with fall incidence in Australian inpatients with dementia
- Author
-
Lit Min Sam, Hugh Eigeland, Sarah C Cameron, Eamonn Eeles, Karen Hay, Samuel X Tan, and Kannan Natarajan
- Subjects
Polypharmacy ,medicine.medical_specialty ,antidepressant ,business.industry ,Incidence (epidemiology) ,RC952-954.6 ,Retrospective cohort study ,General Medicine ,Original Articles ,medicine.disease ,Rate ratio ,Geriatrics ,Emergency medicine ,Cohort ,falls ,Medicine ,Dementia ,Original Article ,neuropsychiatry ,psychotropic ,business ,Adverse effect ,Psychotropic Agent ,dementia - Abstract
Background Persons with dementia commonly experience a range of behavioural and psychological symptoms, including agitation, aggression, perceptual disturbances, and depression. While psychotropic medications are regularly prescribed to mitigate these symptoms, these agents also carry a broad adverse effect profile. This study aimed to characterize psychotropic medication use in patients with dementia, as well as identify prescribing factors associated with falls in this cohort. Methods This retrospective study collected longitudinal demographic and medication data from all patients admitted to a neuro‐cognitive unit at an Australian metropolitan hospital over a 2‐year period. Psychotropic polypharmacy and psychotropic agent use per patient‐fortnight were investigated for their association with inpatient falls. Results All patients (n = 147) were prescribed at least one psychotropic medication, with 96% receiving anti‐psychotic medications and 90% receiving benzodiazepines. Patient fall rate was significantly associated with anticholinergic drug use (Incidence rate ratio: 2.2; P, Patients with dementia are often prescribed psychotropic medications, including antipsychotics and benzodiazepines, to relieve the behavioural and psychological symptoms of dementia. However, this must be counterbalanced against psychotropic adverse effects. Our study demonstrates that anticholinergic medications and psychotropic polypharmacy are associated with fall incidence in patients with dementia.
- Published
- 2021